Nanomedicine and Pharmaceutical Nanotechnology

Biography

Igor Chourpa is Director of Analytical Chemistry Department at the Faculty of Pharmacy of the University François Rabelais of Tours, France, and Head of the research group “Nanomedicine & Nanoprobes” EA6295. This group develops nanomedicines for anticancer theranosis, i.e. diagnosis by medical imaging and therapy by delivery of chemotherapy or siRNA. His particular expertise domain is optical microspectroscopy (Raman, surface-enhanced Raman and fluorescence) and spectral imaging. He has authored 62 publications in peer-reviewed journals. He is member of Editorial Boards of J. Anal. Meth. Chem. (Hindawi) and Int. J. of Nanopart. Nanotechnol. (Helics). 

Abstract

Abstract : Pharmaceutical development of injectable nanomedicine targeting breast cancer